Form 4: John Patience, Bio-Rad Chairman, Buys $75,000 in Biodesix Stock

John Patience, Chairman at Biodesix, recently purchased 75,000 shares of the company's common stock at an average price of $1.3828 per share.

Summary

• John Patience, Chairman of Biodesix, acquired 75,000 shares of common stock on November 5, 2024, at a weighted average price of $1.3828 per share.
• The transactions occurred in multiple purchases with prices ranging from $1.3461 to $1.4186.
• Following the transaction, Patience directly owns 337,926 shares and indirectly owns 2,153,298 shares through Patience Enterprises LP, 4,829,611 shares through John Patience Living Trust dated 7/23/1993 and 52,988 shares through a spouse.
• Patience disclaims beneficial ownership of shares held by Patience Enterprises LP except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the document itself is simply a report of the transaction.

Positives

• The Chairman's purchase could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive signal, suggesting that a company insider believes the stock is undervalued or has confidence in the company's future performance. However, it's just one factor to consider when evaluating a stock.

Stakeholder Impact

• The stock purchase by a key insider could positively influence investor sentiment.

Key Dates